Follow
Ali Nili
Ali Nili
Dana-Farber Cancer Institute, Harvard Medical School
Verified email at dfci.harvard.edu
Title
Cited by
Cited by
Year
Remdesivir: A beacon of hope from Ebola virus disease to COVID‐19
A Nili, A Farbod, A Neishabouri, M Mozafarihashjin, S Tavakolpour, ...
Reviews in Medical Virology 30 (6), 1-13, 2020
342020
Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: a retrospective cohort study
H Mahmoudi, AS Farid, A Nili, D Dayani, S Tavakolpour, T Soori, ...
Journal of the American Academy of Dermatology 84 (4), 1098, 2021
332021
Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial
H Mahmoudi, A Rostami, S Tavakolpour, A Nili, A Teimourpour, ...
Journal of Dermatological Treatment 33 (1), 284-290, 2022
202022
Paradoxical reaction to rituximab in patients with pemphigus: a report of 10 cases
A Nili, S Tavakolpour, H Mahmoudi, P Noormohammadpour, K Balighi, ...
Immunopharmacology and Immunotoxicology 42 (1), 56-58, 2020
202020
Complications of dual growing rod with all-pedicle screw instrumentation in the treatment of early-onset scoliosis
M Zarei, M Tavakoli, E Ghadimi, A Moharrami, A Nili, A Vafaei, ...
Journal of Orthopaedic Surgery and Research 16, 1-6, 2021
152021
Autoimmune Bullous Disease Quality of Life (ABQoL) questionnaire: validation of the translated Persian version in pemphigus vulgaris
A Teimourpour, K Hedayat, F Salarvand, N Ghandi, M Ghiasi, ...
International Journal of Women's Dermatology 6 (4), 306-310, 2020
152020
Vaccine-derived poliovirus infection among patients with primary immunodeficiency and effect of patient screening on disease outcomes, Iran
M Shaghaghi, S Shahmahmoodi, A Nili, H Abolhassani, SP Madani, ...
Emerging Infectious Diseases 25 (11), 2005, 2019
142019
Rituximab in practice: clinical evaluation of patients with pemphigus after rituximab administration
H Mahmoudi, S Tavakolpour, K Balighi, AS Farid, A Nili, D Jan, ...
Dermatologic Therapy 34 (1), e14633, 2021
132021
Closed antegrade/retrograde intramedullary fixation of central metatarsal fractures: surgical technique and clinical outcomes
M Zarei, N Bagheri, A Nili, A Vafaei, E Ghadimi
Injury 51 (4), 1125-1129, 2020
122020
Risk factors of dislocation after total hip arthroplasty in patients with developmental dysplasia of the hip
SMJ Mortazavi, E Ghadimi, MV Ardakani, M Razzaghof, MA Ghasemi, ...
International Orthopaedics, 1-11, 2022
102022
Current status and prospects for the diagnosis of pemphigus vulgaris
A Nili, A Salehi Farid, M Asgari, S Tavakolpour, H Mahmoudi, ...
Expert Review of Clinical Immunology 17 (8), 819-834, 2021
102021
Acute generalized exanthematous pustulosis with a focus on hydroxychloroquine: a 10-year experience in a skin hospital
A Nili, E Zarei, A Ghamari, AS Farid, S Tavakolpour, M Daneshpazhooh, ...
International Immunopharmacology 89, 107093, 2020
102020
Evaluating the efficacy and safety of topical sirolimus 0.2% cream as adjuvant therapy with pulsed dye laser for the treatment of port wine stain: a randomized, double‐blind …
M Fallahi, Z Hallaji, S Tavakolpour, S Niknam, A Salehi Farid, A Nili, ...
Journal of Cosmetic Dermatology 20 (8), 2498-2506, 2021
92021
Treatment of pemphigus patients in the COVID‐19 era: A specific focus on rituximab
H Mahmoudi, S Tavakolpour, A Nili, AS Farid, M Daneshpazhooh, ...
Dermatologic Therapy 33 (6), 2020
62020
Applicability of glucocorticoid toxicity index in pemphigus: Comparison between two groups of rituximab‐treated and rituximab‐naïve patients
E Mazaherpour, N Kianfar, S Dasdar, M Sedaghat, H Seyrafi, K Balighi, ...
Dermatologic Therapy 35 (12), e15902, 2022
52022
Comparing efficacy and safety of potassium hydroxide 5% solution with 5-fluorouracil cream in patients with actinic keratoses: a randomized controlled trial
A Salehi Farid, S Niknam, K Gholami, S Tavakolpour, A Teimourpour, ...
Journal of Dermatological Treatment 33 (3), 1376-1382, 2022
42022
Pustular eruption after biosimilar rituximab infusion: report of acute generalized exanthematous pustulosis in two patients with pemphigus.
M Daneshpazhooh, S Tavakolpour, A Salehi Farid, M Ebadi, A Nili, ...
International Journal of Dermatology 61 (1), 2022
42022
Factors associated with the healing time of pemphigus vulgaris oral lesions: A prospective study
A Nili, S Karimi, A Salehi Farid, P Molhem Azar, Z Farimani, ...
Oral Diseases 29 (5), 2248-2255, 2023
32023
Paradoxical worsening of pemphigus after rituximab presenting as figurate bullous eruption
H Mahmoudi, A Nili, A Salehi Farid, S Tavakolpour, M Daneshpazhooh
British Journal of Dermatology 185 (1), e2-e2, 2021
32021
Evaluation of the possible association between acantholysis and anti‐desmogleins 1 and 3 values in pemphigus vulgaris and pemphigus foliaceus
M Mobarakabadi, N Rajai, K Kamyab, K Balighi, H Mahmoudi, ...
Journal of Cutaneous Immunology and Allergy 2 (6), 169-173, 2019
32019
The system can't perform the operation now. Try again later.
Articles 1–20